title: Microfluidic platform for single nucleotide polymorphism genotyping of the thiopurine S-methyltransferase gene to evaluate risk for adverse drug events.
abstract: Prospective clinical pharmacogenetic testing of the thiopurine S-methyltransferase gene remains to be realized despite the large body of evidence demonstrating clinical benefit for the patient and cost effectiveness for health care systems. We describe an entirely microchip-based method to genotype for common single nucleotide polymorphisms in the thiopurine S-methyltransferase gene that lead to serious adverse drug reactions for patients undergoing thiopurine therapy. Restriction fragment length polymorphism and allele-specific polymerase chain reaction have been adapted to a microfluidic chip-based polymerase chain reaction and capillary electrophoresis platform to genotype the common *2, *3A, and *3C functional alleles. In total, 80 patients being treated with thiopurines were genotyped, with 100% concordance between microchip and conventional methods. This is the first report of single nucleotide polymorphism detection using portable instrumentation and represents a significant step toward miniaturized for personalized treatment and automated point-of-care testing.
authors: Cross Cancer Institute, 11560 University Ave., Edmonton AB T6G1Z2, Canada.
authors: Jeeshan
authors: J
authors: Chowdhury
authors: Govind V
authors: GV
authors: Kaigala
authors: Sudeep
authors: S
authors: Pushpakom
authors: Jana
authors: J
authors: Lauzon
authors: Alistair
authors: A
authors: Makin
authors: Alexey
authors: A
authors: Atrazhev
authors: Alex
authors: A
authors: Stickel
authors: William G
authors: WG
authors: Newman
authors: Christopher J
authors: CJ
authors: Backhouse
authors: Linda M
authors: LM
authors: Pilarski
mesh_terms: D019075:Electrophoresis, Capillary; D005838:Genotype; D006801:Humans; D008780:Methyltransferases / Q000235:genetics*; D046208:Microchip Analytical Procedures; D044085:Microfluidics / Q000379:methods*; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012307:Risk Factors; D013438:Sulfhydryl Compounds / Q000009:adverse effects*
chemical_list: D013438:Sulfhydryl Compounds; D008780:Methyltransferases; C022745:thiopurine methyltransferase
references: Hum Mutat. 1998;12(3):177-85
references: 9711875
references: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W489-92
references: 15980518
references: J Am Soc Nephrol. 2001 Jan;12(1):170-6
references: 11134264
references: Clin Chem. 2001 Mar;47(3):548-55
references: 11238310
references: Clin Pharmacol Ther. 1997 Jul;62(1):60-73
references: 9246020
references: Electrophoresis. 2001 Oct;22(18):3868-75
references: 11700715
references: Anal Chem. 1998 Dec 1;70(23):4974-84
references: 21644679
references: Anal Chem. 2006 Feb 1;78(3):956-8
references: 16448074
references: J Pediatr. 1991 Dec;119(6):985-9
references: 1960624
references: Nature. 2000 Jun 15;405(6788):847-56
references: 10866211
references: Electrophoresis. 2004 Jul;25(14):2346-56
references: 15274017
references: Am J Hum Genet. 1980 Sep;32(5):651-62
references: 7191632
references: Oncogene. 2006 Mar 13;25(11):1629-38
references: 16550163
references: Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Oct;11(5):458-63
references: 14575536
references: Drug Saf. 2006;29(9):735-68
references: 16944962
references: Electrophoresis. 2005 May;26(9):1834-42
references: 15706574
references: Lab Chip. 2005 Oct;5(10):1024-32
references: 16175256
references: Electrophoresis. 2006 Oct;27(19):3753-63
references: 16960845
references: Pharmacogenomics J. 2003;3(2):77-96
references: 12746733
references: Lab Chip. 2003 Nov;3(4):60N-68N
references: 15007447
references: Leukemia. 2000 Apr;14(4):567-72
references: 10764140
references: Rheumatology (Oxford). 2004 Jan;43(1):13-8
references: 14566029
references: Genome Res. 2001 Mar;11(3):413-21
references: 11230165
references: Anal Bioanal Chem. 2006 Oct;386(3):427-34
references: 16821029
references: Genome Res. 2000 Sep;10(9):1403-13
references: 10984458
references: Mol Carcinog. 1993;7(4):263-7
references: 8102530
references: Lancet. 2006 Mar 11;367(9513):839-46
references: 16530578
references: Clin Chem. 2004 Feb;50(2):288-95
references: 14656901
references: Nat Biotechnol. 2000 May;18(5):505-8
references: 10802616
references: Pharmacogenomics J. 2006 Jan-Feb;6(1):3-7
references: 16314885
references: Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6444-9
references: 9177237
references: Clin Chem. 2001 Feb;47(2):173-85
references: 11159764
references: Ther Drug Monit. 2004 Apr;26(2):186-91
references: 15228163
references: Arch Dis Child. 1993 Nov;69(5):577-9
references: 8257179
references: Trends Pharmacol Sci. 2001 Jun;22(6):298-305
references: 11395158
references: Drug Metab Rev. 2003 Nov;35(4):277-85
references: 14705861
references: Electrophoresis. 2000 Jan;21(1):3-11
references: 10634466
references: Genet Test. 2003 Winter;7(4):283-93
references: 15000804
references: Ann Intern Med. 1997 Apr 15;126(8):608-14
references: 9103127
references: Nat Biotechnol. 1998 Jan;16(1):40-4
references: 9447591
references: World J Gastroenterol. 2006 Jun 21;12(23):3657-67
references: 16773681
references: Nat Rev Drug Discov. 2005 Aug;4(8):639-47
references: 16056390
references: Analyst. 2004 Jan;129(1):25-31
references: 14737579
references: Anal Chem. 2005 Jul 1;77(13):4000-7
references: 15987103
references: Pharmacogenetics. 1998 Aug;8(4):283-9
references: 9731714
references: Nature. 2006 Jul 27;442(7101):368-73
references: 16871203
references: Anal Chem. 2005 Jun 15;77(12):3887-93
references: 15952761